These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 2196030)
1. [Treatment of severe hyaline membrane disease with a single-dose of natural exogenous surfactant of porcine origin. A randomized trial: immediate effects and outcome at 28 days of life]. Walti H; Relier JP; Huon C; Monset-Couchard M; Scemama M; De Gamarra E; Moriette G; Curstedt T; Robertson B Arch Fr Pediatr; 1990 May; 47(5):329-34. PubMed ID: 2196030 [TBL] [Abstract][Full Text] [Related]
2. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Collaborative European Multicenter Study Group. Pediatrics; 1988 Nov; 82(5):683-91. PubMed ID: 2903480 [TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease. Gitlin JD; Soll RF; Parad RB; Horbar JD; Feldman HA; Lucey JF; Taeusch HW Pediatrics; 1987 Jan; 79(1):31-7. PubMed ID: 3540835 [TBL] [Abstract][Full Text] [Related]
4. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial. Rojas MA; Lozano JM; Rojas MX; Laughon M; Bose CL; Rondon MA; Charry L; Bastidas JA; Perez LA; Rojas C; Ovalle O; Celis LA; Garcia-Harker J; Jaramillo ML; Pediatrics; 2009 Jan; 123(1):137-42. PubMed ID: 19117872 [TBL] [Abstract][Full Text] [Related]
5. Role of early postnatal dexamethasone in respiratory distress syndrome. Mukhopadhyay K; Kumar P; Narang A Indian Pediatr; 1998 Feb; 35(2):117-22. PubMed ID: 9707853 [TBL] [Abstract][Full Text] [Related]
6. Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease. Phibbs RH; Ballard RA; Clements JA; Heilbron DC; Phibbs CS; Schlueter MA; Sniderman SH; Tooley WH; Wakeley A Pediatrics; 1991 Jul; 88(1):1-9. PubMed ID: 2057244 [TBL] [Abstract][Full Text] [Related]
7. Exogenous surfactant replacement therapy of hyaline membrane disease in premature infants. Namgung R; Lee C; Suh JS; Park KI; Han DG Yonsei Med J; 1989 Dec; 30(4):355-66. PubMed ID: 2697112 [TBL] [Abstract][Full Text] [Related]
8. [The therapeutic use of pulmonary surfactant in neonatal hyaline membrane disease]. Lozano-González CH; Piña-Ceballos VM; Beyer-Obezo J; Gutiérrez-Martín A; Martínez-Hinojosa B; Flores-Támez ME Bol Med Hosp Infant Mex; 1993 Jul; 50(7):481-91. PubMed ID: 8363747 [TBL] [Abstract][Full Text] [Related]
9. Comparison outcomes of surfactant therapy in respiratory distress syndrome in two periods. Chotigeat U; Promwong N; Kanjanapattanakul W; Khorana M; Sangtawesin V; Horpaopan S J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S109-14. PubMed ID: 19253505 [TBL] [Abstract][Full Text] [Related]
10. Double-blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants. Kwong MS; Egan EA; Notter RH; Shapiro DL Pediatrics; 1985 Oct; 76(4):585-92. PubMed ID: 3900906 [TBL] [Abstract][Full Text] [Related]
12. The effects of surfactant and antenatal corticosteroid treatment on the pulmonary pathology of preterm infants with respiratory distress syndrome. Teksam O; Kale G Pathol Res Pract; 2009; 205(1):35-41. PubMed ID: 18951732 [TBL] [Abstract][Full Text] [Related]
13. Bovine surfactant (surfactant TA) therapy in immature baboons with hyaline membrane disease. Vidyasagar D; Maeta H; Raju TN; John E; Bhat R; Go M; Dahiya U; Roberson Y; Yamin A; Narula A Pediatrics; 1985 Jun; 75(6):1132-42. PubMed ID: 3846883 [TBL] [Abstract][Full Text] [Related]
14. [Effects of surfactant administration in premature infants with severe respiratory distress syndrome]. Morón A; Luaces J; Esteban JC; Medina D; Sánchez JM; Manzano JL Med Clin (Barc); 1996 Jun; 107(5):165-8. PubMed ID: 8758674 [TBL] [Abstract][Full Text] [Related]
15. The late administration of surfactant. Ballot DE; Rothberg AD; Davies VA S Afr Med J; 1995 Jul; 85(7):644-6. PubMed ID: 7482080 [TBL] [Abstract][Full Text] [Related]
16. Early and late surfactant treatments in baboon model of hyaline membrane disease. Maeta H; Vidyasagar D; Raju TN; Bhat R; Matsuda H Pediatrics; 1988 Feb; 81(2):277-83. PubMed ID: 3340477 [TBL] [Abstract][Full Text] [Related]
17. Effects of exogenous surfactant therapy on dynamic compliance during mechanical breathing in preterm infants with hyaline membrane disease. Couser RJ; Ferrara TB; Ebert J; Hoekstra RE; Fangman JJ J Pediatr; 1990 Jan; 116(1):119-24. PubMed ID: 2404097 [TBL] [Abstract][Full Text] [Related]